Oxindole synthesis by palladium-catalysed aromatic C–H alkenylation
Authors:
- 25 February 2010
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 46 (14) , 2462-2464
Abstract
A strategy involving palladium-catalysed aromatic C–H functionalisation/intramolecular alkenylation provides a convenient and direct synthesis of 3-alkylideneoxindoles. In the presence of 5 mol% of PdCl2MeCN2 and AgOCOCF3, a wide variety of N-cinnamoylanilines gave 3-alkylideneoxindoles in moderate to good yield.Keywords
This publication has 40 references indexed in Scilit:
- Telescoped Enolate Arylation/HWE Procedure for the Preparation of 3‐Alkenyl‐Oxindoles: The First Synthesis of SoulieotineEuropean Journal of Organic Chemistry, 2009
- Enantioselective Synthesis of SM-130686 Based on the Development of Asymmetric Cu(I)F Catalysis To Access 2-Oxindoles Containing a Tetrasubstituted CarbonJournal of the American Chemical Society, 2009
- Chiral N-heterocyclic carbene ligands for asymmetric catalytic oxindole synthesisChemical Communications, 2008
- Palladium‐Catalyzed Tandem Heck Reaction/C-H Functionalization—Preparation of Spiro‐Indane‐OxindolesAngewandte Chemie International Edition, 2008
- Palladium-Catalyzed Carbonylative Annulation Reaction of 2-(1-Alkynyl)benzenamines: Selective Synthesis of 3-(Halomethylene)indolin-2-onesOrganic Letters, 2007
- Assembly of 3-Acyloxindoles via CuI/l-Proline-Catalyzed Intramolecular Arylation of β-Keto AmidesOrganic Letters, 2006
- Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindolesBioorganic & Medicinal Chemistry Letters, 2004
- Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine KinasesJournal of Medicinal Chemistry, 1998
- Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH GroupJournal of Medicinal Chemistry, 1996
- Discovery of micromolar PDE IV inhibitors that exhibit much reduced affinity for the [3H]rolipram binding site: 3-norbornyloxy-4-methoxyphenylmethylene oxindolesBioorganic & Medicinal Chemistry Letters, 1995